John Wilkin
Stock Analyst at Craig-Hallum
(2.29)
# 2,343
Out of 4,981 analysts
5
Total ratings
60%
Success rate
9.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $9.74 | +23.20% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $12.61 | +18.95% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $30.88 | +45.73% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $5.85 | +36.75% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $7.24 | +300.55% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $9.74
Upside: +23.20%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $12.61
Upside: +18.95%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $30.88
Upside: +45.73%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $5.85
Upside: +36.75%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $7.24
Upside: +300.55%